Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$0.16 - $0.47 $102,545 - $301,226
640,908 Added 2908.06%
662,947 $111,000
Q1 2022

May 16, 2022

SELL
$0.42 - $0.62 $61,639 - $90,991
-146,760 Reduced 86.94%
22,039 $10,000
Q4 2021

Feb 14, 2022

BUY
$0.56 - $1.71 $60,661 - $185,234
108,324 Added 179.12%
168,799 $96,000
Q3 2021

Nov 15, 2021

BUY
$1.21 - $1.8 $8,733 - $12,992
7,218 Added 13.55%
60,475 $100,000
Q2 2021

Aug 16, 2021

SELL
$1.56 - $1.98 $577,473 - $732,946
-370,175 Reduced 87.42%
53,257 $88,000
Q1 2021

May 17, 2021

BUY
$1.36 - $2.49 $431,243 - $789,556
317,091 Added 298.18%
423,432 $716,000
Q4 2020

Feb 16, 2021

BUY
$0.75 - $2.76 $34,911 - $128,475
46,549 Added 77.85%
106,341 $169,000
Q3 2020

Nov 16, 2020

BUY
$0.61 - $1.17 $15,469 - $29,671
25,360 Added 73.65%
59,792 $57,000
Q2 2020

Aug 14, 2020

SELL
$0.47 - $0.72 $72,886 - $111,656
-155,078 Reduced 81.83%
34,432 $22,000
Q1 2020

May 15, 2020

BUY
$0.36 - $0.74 $51,014 - $104,863
141,707 Added 296.44%
189,510 $79,000
Q4 2019

Feb 14, 2020

SELL
$0.35 - $0.58 $5,901 - $9,778
-16,860 Reduced 26.07%
47,803 $28,000
Q3 2019

Nov 14, 2019

SELL
$0.38 - $0.52 $81 - $111
-215 Reduced 0.33%
64,663 $32,000
Q2 2019

Aug 14, 2019

BUY
$0.39 - $0.7 $14,564 - $26,141
37,345 Added 135.64%
64,878 $25,000
Q1 2019

May 15, 2019

SELL
$0.43 - $0.68 $43,665 - $69,052
-101,548 Reduced 78.67%
27,533 $0
Q4 2018

Feb 14, 2019

BUY
$0.39 - $0.7 $41,846 - $75,108
107,298 Added 492.58%
129,081 $50,000
Q3 2018

Nov 13, 2018

SELL
$0.44 - $3.02 $10,019 - $68,768
-22,771 Reduced 51.11%
21,783 $0
Q2 2018

Aug 10, 2018

BUY
$1.66 - $3.82 $6,817 - $15,688
4,107 Added 10.15%
44,554 $0
Q1 2018

May 11, 2018

BUY
$2.16 - $3.48 $64,912 - $104,580
30,052 Added 289.1%
40,447 $138,000
Q4 2017

Feb 09, 2018

SELL
$0.68 - $4.19 $5,378 - $33,138
-7,909 Reduced 43.21%
10,395 $42,000
Q3 2017

Nov 09, 2017

BUY
$0.38 - $0.66 $6,955 - $12,080
18,304
18,304 $11,000

Others Institutions Holding AMPE

# of Institutions
1
Shares Held
96.6K
Call Options Held
0
Put Options Held
0

About Ampio Pharmaceuticals, Inc.


  • Ticker AMPE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,287,008
  • Description
  • Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...
More about AMPE
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.